respiratori
infect
associ
wheez
ill
age
may
also
impact
develop
sever
asthma
respiratori
tract
infect
caus
virus
chlamydophila
mycoplasma
hypothes
signific
role
pathogenesi
asthma
progress
made
toward
establish
mechan
agent
caus
acut
wheez
impact
pathophysiolog
asthma
host
factor
probabl
contribut
risk
asthma
incept
exacerb
contribut
may
also
vari
respect
earlyversu
adultonset
diseas
review
discuss
variou
associ
pertain
develop
exacerb
asthma
exacerb
sever
chronic
asthma
final
colon
upper
airway
infanc
common
bacteri
pathogen
demonstr
increas
risk
subsequ
asthma
review
variou
associ
pertain
develop
exacerb
asthma
incid
noninfecti
risk
factor
remiss
childhood
adultonset
asthma
diseas
sever
studi
document
incid
asthma
peak
earli
childhood
rate
high
five
new
case
per
popul
per
year
commonli
boy
incid
declin
adolesc
climb
earli
adulthood
revers
gender
predilect
favor
women
onset
puberti
wherea
eczema
famili
histori
asthma
domin
noninfecti
risk
factor
pediatr
asthma
trigger
adultonset
diseas
less
well
defin
occup
exposur
person
histori
smoke
contribut
minor
case
wherea
either
allerg
nonatop
rhiniti
associ
adult
onset
diseas
multipl
studi
respect
remiss
rate
chanc
remiss
asthma
patient
develop
diseas
year
age
adultonset
diseas
consist
notion
pediatr
adult
asthma
may
import
clinic
differ
latter
higher
incid
steroid
resist
complic
manag
nonetheless
respiratori
infect
common
acut
inflammatori
trigger
incid
asthma
two
common
viral
ill
lead
lower
respiratori
tract
infect
lri
wheez
infanc
caus
respiratori
syncyti
viru
rsv
human
rhinovirus
hrv
use
multipl
viru
detect
method
jartti
colleagu
determin
etiolog
wheez
ill
hospit
children
infant
viru
detect
rsv
picornaviru
hrv
enteroviru
human
metapneumoviru
hmpv
rate
hospit
infant
bronchiol
increas
substanti
rsv
etiolog
approxim
episod
older
children
respiratori
picornavirus
domin
children
age
year
children
age
year
howev
bronchiol
sever
form
rsv
infect
occur
minor
children
year
age
children
infect
viru
year
age
nearli
infect
children
month
age
born
close
onset
viral
season
higher
likelihood
develop
lower
respiratori
tract
symptom
like
due
airway
lung
parenchyma
andor
immunolog
matur
furthermor
child
born
month
winter
viru
peak
predict
increas
risk
childhood
asthma
addit
risk
factor
bronchiol
includ
antivir
immun
respons
innat
adapt
gender
lung
size
passiv
smoke
exposur
sever
larg
prospect
studi
children
demonstr
rsv
bronchiol
import
risk
factor
recurr
wheez
asthma
first
decad
life
longitudin
populationbas
cohort
studi
shown
associ
rsv
lri
frequent
three
episod
infrequ
three
episod
wheez
diminish
markedli
age
becom
nonsignific
year
age
wherea
earli
rsv
neg
infecti
agent
group
continu
confer
risk
frequent
wheez
decreas
associ
wheez
rsv
lri
increas
age
also
observ
investig
data
suggest
although
rsv
infect
increas
risk
recurr
wheez
asthma
earli
childhood
genet
environment
development
factor
modifi
express
asthma
phenotyp
time
although
bronchiol
infanc
associ
approxim
twofold
increas
risk
earli
childhood
asthma
risk
differ
season
bronchiol
bronchiol
occur
hrvpredomin
month
spring
fall
associ
estim
increas
likelihood
earli
childhood
asthma
compar
rsvpredomin
winter
month
howev
proport
associ
asthma
winter
season
bronchiol
greater
hrvpredomin
month
owe
larger
number
children
affect
rsv
bronchiol
similarli
shown
children
nonrsv
bronchiol
develop
recurr
wheez
compar
children
rsv
bronchiol
anoth
studi
kusel
cowork
demonstr
although
rsv
associ
sever
lri
requir
hospit
hrv
associ
threetim
number
wheez
nonwheez
lri
infanc
addit
author
found
acut
sever
lri
caus
hrv
rsv
first
year
life
strongli
associ
diagnosi
current
asthma
persist
wheez
children
particularli
sensit
infanc
jackson
cowork
also
demonstr
larg
highrisk
cohort
children
increas
risk
asthma
year
age
wheez
first
year
life
rsv
odd
ratio
hrv
hrv
rsv
year
age
wheez
hrv
strongli
associ
asthma
year
age
aeroallergen
sensit
similarli
strong
associ
earlylif
hrv
wheez
increas
risk
recurr
wheez
asthma
demonstr
sever
studi
find
support
concept
hrv
import
caus
bronchiol
strongli
associ
risk
asthma
develop
host
factor
allerg
sensit
decreas
lung
function
infanc
may
also
influenc
develop
recurr
wheez
andor
asthma
premorbid
measur
lung
function
indic
children
reduc
level
lung
function
infanc
appear
increas
risk
develop
chronic
lower
respiratori
tract
sequela
viral
infect
obstruct
pattern
lung
function
adulthood
whether
reduc
lung
function
alon
respons
develop
present
unknown
children
earli
allerg
sensit
year
age
like
diagnos
current
wheez
asthma
lri
rsv
hrv
infanc
thu
viral
infect
act
synergist
allerg
sensit
reduc
lung
function
infanc
lead
asthma
later
life
associ
viral
infect
asthma
exacerb
illumin
develop
sensit
diagnost
test
base
pcr
andor
microarray
technolog
virus
difficult
cultur
hrv
hmpv
bocavirus
advent
sensit
diagnost
tool
inform
link
common
cold
infect
exacerb
asthma
come
number
sourc
prospect
studi
subject
asthma
demonstr
exacerb
wheez
asthma
children
caus
viral
infect
rate
high
adult
season
trend
occur
week
later
children
suggest
household
transmiss
strain
hrv
often
detect
especi
spring
fall
season
inde
spring
fall
peak
asthma
hospit
correl
pattern
hrv
detect
within
commun
hrv
infect
frequent
found
children
older
year
age
present
emerg
depart
acut
wheez
children
hospit
acut
asthma
newli
discov
hrv
speci
hrvc
associ
asthma
flare
children
fall
winter
new
strain
hrv
coronavirus
identifi
virochip
method
adult
rsv
like
trigger
acut
asthma
symptom
wintertim
like
account
smaller
proport
overal
asthma
exacerb
influenza
infect
also
associ
increas
healthcar
util
among
children
asthma
compar
healthi
children
bocavirus
associ
acut
wheez
episod
children
virus
less
frequent
associ
exacerb
asthma
includ
metapneumoviru
coronavirus
togeth
studi
provid
evid
strong
relationship
viral
infect
particularli
due
hrv
acut
exacerb
asthma
hypothes
chronic
viral
bacteri
infect
colon
pathogen
bacteria
could
lead
chronic
lower
airway
inflamm
impair
mucociliari
clearanc
increas
mucou
product
eventu
asthma
organ
implic
progress
includ
adenovirus
chlamydophila
pneumonia
mycoplasma
pneumonia
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
respect
former
latent
adenovir
infect
persist
airway
mani
year
latent
infect
defin
viru
insert
part
viru
genom
host
cell
dna
continu
period
express
viral
gene
demonstr
children
steroidresist
asthma
detect
adenoviru
antigen
compar
control
adult
without
asthma
evid
adenovir
infect
observ
high
individu
test
literatur
regard
associ
chronic
mycobacterium
chlamydophila
infect
asthma
children
adult
howev
studi
produc
contradictori
result
probabl
due
limit
current
diagnost
find
diagnost
test
upper
lower
airway
alway
agre
diagnosi
infect
serolog
imprecis
previous
first
relationship
asthma
c
pneumonia
describ
wheez
adult
asthmat
patient
nine
found
serolog
evid
current
recent
infect
pathogen
schoolag
children
wheez
surprisingli
high
preval
lowgrad
c
pneumonia
infect
nasal
aspir
observ
detect
c
pneumonia
infect
pcr
serolog
secretori
iga
similar
symptomat
asymptomat
episod
vs
respect
children
experienc
multipl
episod
also
tend
remain
pcr
posit
c
pneumonia
suggest
chronic
infect
moreov
c
pneumoniaespecif
secretori
iga
antibodi
level
seventim
higher
subject
report
four
exacerb
studi
compar
report
one
studi
pediatr
patient
flexibl
fiber
optic
bronchoscopi
pcr
c
pneumoniaeposit
sampl
patient
asthma
cultur
blood
sampl
reveal
significantli
higher
proport
asthma
subject
posit
chlamydia
compar
match
nonrespiratori
control
subject
possibl
chronic
chlamydophila
infect
promot
persist
airway
inflamm
increas
suscept
stimuli
virus
allergen
associ
asthma
exacerb
comprehens
evalu
role
chlamydophila
mycoplasma
infect
chronic
asthma
report
johnston
et
al
author
conclud
although
mani
studi
investig
associ
asthma
pathogen
uncontrol
provid
conflict
evid
biolog
mechan
could
account
link
may
role
antibacteri
therapi
manag
asthma
martin
et
al
evalu
adult
patient
chronic
asthma
percent
predict
forc
expiratori
volum
fev
control
infect
mycoplasma
c
pneumonia
virus
influenza
b
parainfluenza
rsv
hrv
adenoviru
evalu
bronchoalveolar
lavag
cell
count
differenti
well
tissu
morphometri
also
perform
asthmat
patient
posit
pcr
pneumonia
n
c
pneumonia
n
mainli
found
lavag
fluid
biopsi
sampl
one
control
subject
posit
pcr
mycoplasma
significantli
greater
number
tissu
mast
cell
observ
group
patient
posit
pcr
compar
neg
cultur
organ
neg
patient
serolog
confirm
poor
correl
pcr
result
anoth
studi
biscardi
et
al
children
age
year
asthma
hospit
sever
asthma
exacerb
test
acut
infect
due
pneumonia
c
pneumonia
serolog
test
nasopharyng
aspir
pcr
also
perform
acut
pneumonia
infect
posit
serolog
found
c
pneumonia
infect
found
patient
current
exacerb
patient
experienc
first
asthma
flare
acut
pneumonia
infect
demonstr
c
pneumonia
patient
children
infect
pneumonia
c
pneumonia
experienc
first
asthma
exacerb
recurr
asthma
without
infect
recurr
asthma
similar
previou
studi
serolog
confirm
correl
poorli
pcr
result
thu
chronic
chlamydophila
infect
may
promot
ongo
airway
inflamm
investig
theoriz
mechan
develop
c
pneumoniaespecif
ige
antibodi
facilit
releas
mediat
caus
bronchospasm
airway
inflamm
airway
reactiv
unless
infect
treat
antigen
stimul
promot
specif
ige
product
would
continu
thu
produc
prolong
cours
asthma
patient
unrespons
bronchodil
steroid
major
c
pneumonia
antigen
heatshock
protein
implic
stimul
deleteri
immun
respons
human
chlamydi
infect
observ
coloc
infiltr
macrophag
atheromat
lesion
report
power
induc
macrophag
inflammatori
respons
mediat
innat
immun
receptor
complex
tolllik
receptor
tlr
taken
togeth
find
impli
chronic
asymptomat
chlamydi
infect
may
affect
persist
airway
inflammatori
respons
innat
adapt
immun
respons
state
previous
pneumonia
also
associ
acut
chronic
asthma
result
trial
contradictori
investig
abl
firmli
establish
causal
relationship
mycoplasm
infect
asthma
exacerb
although
report
infect
children
wheez
other
abl
confirm
observ
moreov
group
children
evalu
rel
contribut
mycoplasm
chlamydi
infect
acut
exacerb
virus
far
common
etiolog
possibl
associ
may
becom
establish
sensit
specif
serolog
diagnost
test
becom
avail
andor
cultur
techniqu
improv
unlik
inconsist
relationship
mycoplasma
speci
acut
asthma
exacerb
associ
pathogen
chronic
asthma
firmli
establish
previous
mention
use
pcr
techniqu
bronchial
biopsi
specimen
mycoplasma
speci
detect
adult
asthmat
subject
one
control
case
report
chronic
asthma
commenc
pneumonia
infect
suggest
pathogen
potenti
caus
agent
patient
potenti
mechan
mycoplasmainduc
airway
inflamm
explor
includ
augment
respons
inflammatori
neuropeptid
children
acut
pneumonia
elev
ratio
compar
children
pneumococc
pneumonia
control
mice
experiment
infect
pneumonia
develop
airway
hyperrespons
ahr
associ
diminish
product
mrna
last
asthmat
patient
pneumonia
infect
detect
pcr
increas
level
decreas
respons
treatment
macrolid
antibiot
microbiom
lower
airway
thoroughli
evalu
date
grow
sens
steril
compart
constitu
may
differ
healthi
person
patient
asthma
recent
studi
bisgaard
cowork
found
neonat
colon
hypopharyng
region
pneumonia
h
influenza
catarrhali
combin
organ
increas
risk
recurr
earlylif
wheez
asthma
year
age
although
preliminari
studi
intrigu
addit
data
need
establish
causal
asthma
pathogenesi
defin
mechan
contribut
associ
adult
pediatr
patient
anoth
possibl
mechan
associ
person
immun
function
bias
toward
atopi
may
alter
host
defens
increas
suscept
bacteri
viral
infect
increas
risk
develop
asthma
collect
studi
regard
chronic
bacteri
infectioncolon
form
basi
random
placebocontrol
doubleblind
clinic
trial
prolong
cours
macrolid
antibiot
acut
chronic
asthma
control
effect
drug
unfortun
variabl
depend
popul
sever
mechan
propos
elucid
respiratori
virus
lead
wheez
ill
exacerb
asthma
first
viral
infect
injur
airway
epitheli
cell
initi
airway
edema
leakag
serum
protein
airway
along
shed
infect
cell
airway
effect
lead
obstruct
wheez
furthermor
virusinduc
immun
respons
essenti
clear
viral
infect
may
also
contribut
symptom
airway
hyperact
caus
influx
inflammatori
cell
neg
impact
lower
airway
physiolog
respiratori
virus
augment
airway
inflamm
directli
infect
lower
airway
tissu
perhap
infect
upper
airway
initi
system
immun
respons
promot
lower
airway
inflamm
environment
factor
may
act
synergist
viral
infect
known
trigger
lead
acut
exacerb
allerg
sensit
increas
risk
develop
asthma
virusinduc
wheez
episod
infanc
strongli
relat
virusinduc
exacerb
asthma
older
children
adult
asthma
exampl
effect
viral
infect
sever
asthma
exacerb
may
augment
exposur
allergen
individu
sensit
exposur
increas
level
air
pollut
also
possibl
allerg
sensit
alon
may
increas
suscept
viral
infect
hrv
although
gener
cohort
adult
patient
asthma
appear
get
uri
compar
healthi
cohabit
similar
exposur
observ
studi
adult
children
suggest
low
vitamin
serum
level
higher
incid
virusinduc
asthma
exacerb
relationship
low
vitamin
statu
asthma
support
number
observ
first
genet
polymorph
vitamin
receptordepend
pathway
associ
develop
asthma
second
vitamin
defici
may
relat
season
variat
symptomat
respiratori
infect
even
southern
climat
despit
greater
potenti
cutan
synthesi
low
vitamin
statu
common
third
mechanist
studi
shown
vitamin
treatment
increas
product
alter
mhc
tlr
express
enhanc
tregulatori
cell
suppress
final
vitamin
treatment
airway
epitheli
cell
promot
differenti
sens
may
promot
heal
epitheli
barrier
defens
undifferenti
basal
cell
easili
infect
basic
clinic
observ
remain
determin
whether
vitamin
supplement
decreas
rate
infecti
ill
andor
asthma
exacerb
sever
group
postul
airway
epithelium
regul
immun
respons
environment
injuri
includ
induc
respiratori
infect
key
differ
respons
distinguish
healthi
control
patient
asthma
may
even
contribut
asthma
incept
repeat
asthma
exacerb
damag
airway
epithelium
contribut
loss
lung
function
studi
describ
patch
denud
airway
asthmat
patient
baselin
good
symptom
control
observ
healthi
control
although
differ
univers
found
epitheli
experi
vitro
suggest
rel
healthi
control
asthmat
epitheli
cell
slower
differenti
form
tight
junction
barrier
defens
produc
numer
inflammatori
mediat
import
innat
immun
varieti
insult
denud
airway
also
associ
vascular
leak
cellular
inflamm
contribut
wors
symptom
control
addit
viral
exposur
may
promot
dysfunct
ciliatogoblet
cell
transit
depend
egf
receptor
exposur
term
epitheli
repair
mechan
appear
key
cytokin
distinguish
asthma
patient
way
may
prolong
cours
toward
restor
normal
barrier
function
product
airway
increas
asthmat
part
due
wellestablish
genet
variant
promot
goblet
cell
format
hypersecret
mucin
rel
expens
tight
junctionform
ciliat
epithelium
import
epitheli
celliniti
recruit
eosinophil
via
eotaxin
product
gener
sens
cytokin
enhanc
profibrot
repair
phenotyp
perspect
genomewid
airway
epitheli
cell
express
array
studi
identifi
three
gene
form
signatur
distinguish
asthma
patient
healthi
control
repress
gene
inhal
corticosteroid
ic
clinic
trial
presenc
also
downregul
ifn
respons
stimul
pathway
may
contribut
select
suscept
prolong
infect
patient
asthma
much
attent
focus
late
role
ifn
produc
viral
infect
bind
intercellular
adhes
molecul
icam
low
densiti
lipoprotein
ldl
receptor
major
minor
group
hrv
respect
entri
uncoat
occur
ifn
rapidli
induc
hrvstimul
signal
via
transcript
factor
well
activ
rna
helicas
retino
acidinduc
gene
rig
melanoma
differenti
antigen
mda
activ
transcript
factor
interferon
regulatori
factor
epitheli
cell
product
particular
respons
stimul
mani
gene
subsequ
induc
hrv
signific
interest
johnston
colleagu
shown
undifferenti
airway
epitheli
cell
product
respons
hrv
discern
healthi
subject
asthmat
howev
differ
observ
use
genomewid
express
array
candid
gene
quantit
pcr
summari
wide
recognit
airway
epitheli
cell
key
compon
innat
defens
asthmaspecif
defect
epithelialdirect
airway
repair
infect
respons
may
regul
respons
epitheli
cell
hrv
infect
import
asthma
howev
mechan
warrant
studi
cellular
inflammatori
respons
upper
airway
may
hold
key
determin
hrv
control
differ
asthmat
patient
classic
longitudin
cohort
studi
patient
asthma
get
similar
number
cold
healthi
cohabit
asthma
approxim
twofold
greater
risk
lower
airway
infect
greater
durat
intens
symptom
suggest
asthmat
possess
inabl
effici
contain
viru
initi
upper
airway
inflammatori
respons
regard
potenti
mechan
upper
airway
epitheli
cell
resist
rhinovir
infect
bronchial
cell
howev
occur
healthi
asthma
subject
nasal
chemokin
associ
neutrophil
influx
cold
symptom
interestingli
subject
allerg
rhiniti
three
nasal
challeng
allergen
suffici
promot
nasal
eosinophilia
week
experiment
cold
delay
onset
shorter
durat
cold
symptom
compar
placeboprim
hrvchalleng
group
upper
airway
neutrophil
influx
natur
acquir
asthmat
viral
cold
shown
invers
associ
subsequ
develop
lower
airway
symptom
although
multivari
model
novel
asthma
biomark
pore
function
nucleotid
receptor
predict
loss
control
leukocyteepitheli
cell
trimer
cation
channelpor
amplifi
tlrdepend
immun
respons
presenc
danger
signal
atp
present
airway
higher
concentr
allerg
viral
challeng
summar
initi
epitheli
cell
respons
infect
upper
airway
may
modifi
sever
host
factor
import
asthma
pathophysiolog
attenu
microbi
clearanc
contribut
greater
risk
lower
airway
infect
asthma
symptom
respiratori
syncyti
viru
influenza
infect
wellrecogn
caus
bronchiti
bronchiol
pneumonia
histor
hrv
consid
sole
upper
airway
pathogen
associ
common
cold
symptom
observ
hrv
replic
best
thought
consist
temperatur
upper
airway
fact
lower
airway
temperatur
record
use
bronchoscop
equip
small
thermistor
quiet
breath
room
temperatur
airway
temperatur
favor
hrv
replic
fourthgener
bronchi
surpass
peripheri
lung
furthermor
hrv
appear
replic
equal
well
cultur
epitheli
cell
deriv
either
upper
lower
airway
epithelium
although
find
univers
final
hrv
observ
lower
airway
cell
secret
sever
techniqu
experiment
inocul
support
experiment
infect
model
data
hrv
frequent
found
infant
children
lower
respiratori
sign
symptom
includ
children
hospit
pneumonia
infant
recurr
respiratori
symptom
hrv
detect
lower
airway
bronchial
biopsi
major
hrvposit
infant
also
show
increas
airway
resist
viral
clearanc
may
also
affect
asthma
two
studi
adult
condit
stabl
diseas
demonstr
evid
viral
pathogen
sputum
sampl
transbronchi
lung
biopsi
togeth
find
impli
respiratori
virus
includ
hrv
like
promot
wheez
ill
exacerb
asthma
larg
infect
lower
airway
caus
augment
lower
airway
inflamm
pathogen
may
incomplet
clear
select
patient
featur
propos
model
epitheli
celldepend
promot
asthma
symptom
review
figur
effect
allerg
sensit
asthmat
airway
respons
viral
infect
topic
much
research
relationship
two
factor
appear
bidirect
atop
state
alter
lower
airway
respons
viral
infect
viral
infect
affect
develop
allergen
sensit
synergist
interact
emerg
individu
expos
concurr
allergen
virus
previous
suggest
atop
individu
may
alter
host
defens
increas
suscept
bacteri
viral
infect
increas
risk
develop
asthma
atopi
risk
factor
develop
childhood
asthma
virusinduc
wheez
ill
mani
investig
group
explor
mechan
relationship
also
propos
atopi
may
import
predispos
factor
develop
acut
bronchiol
rsv
epidem
investig
report
atop
parent
increas
likelihood
children
develop
persist
wheez
wherea
other
observ
similarli
controversi
whether
person
atopi
preval
bronchiol
albeit
clear
children
wheez
earli
life
atop
featur
allerg
sensit
atop
dermat
either
blood
eosinophilia
allergenspecif
ige
highest
risk
later
asthma
find
led
develop
predict
indic
estim
risk
asthma
wheez
infanc
data
support
allerg
sensit
risk
factor
wheez
common
cold
infect
later
childhood
emerg
depart
set
risk
factor
associ
acut
wheez
episod
report
includ
detect
respiratori
viru
commonli
hrv
posit
allergenspecif
ige
presenc
eosinophilia
notabl
viral
infect
allerg
inflamm
synergist
augment
risk
wheez
moreov
experiment
inocul
hrv
like
increas
airway
respons
allerg
individu
compar
nonallerg
individu
final
risk
hospit
among
virusinfect
individu
amplifi
patient
sensit
expos
respiratori
allergen
result
impli
individu
respiratori
allergi
eosinophil
airway
inflamm
increas
risk
viralinduc
wheez
howev
theori
confirm
experiment
induc
cold
allergen
administr
viral
inocul
increas
cold
symptom
viral
infect
propos
interact
allerg
inflamm
lead
airway
dysfunct
sever
mechan
viral
infect
could
potenti
damag
barrier
function
airway
epithelium
lead
enhanc
absorpt
aeroallergen
across
airway
wall
subsequ
inflamm
moreov
product
variou
cytokin
chemokin
leukotrien
adhes
molecul
may
upregul
cellular
recruit
cell
activ
ongo
inflammatori
respons
sever
studi
also
demonstr
hrv
infect
increas
airway
hyperrespons
patient
atopi
asthma
final
recent
studi
demonstr
use
prednisolon
associ
less
recurr
wheez
young
children
hrv
infect
rsv
nonhrvrsv
infect
thu
hrv
infect
may
marker
wheez
children
respond
favor
corticosteroid
treatment
respiratori
infect
particularli
caus
virus
signific
caus
wheez
ill
age
progress
made
toward
establish
mechan
agent
caus
acut
wheez
impact
pathophysiolog
asthma
whether
true
asthmagen
strain
virus
requir
addit
epidemiolog
studi
sever
cold
season
sampl
divers
geograph
region
host
factor
like
contribut
risk
asthma
incept
exacerb
contribut
may
also
vari
respect
earlyversu
adultonset
diseas
includ
epitheli
barrier
defens
interferon
andor
danger
receptor
mechan
understood
may
possibl
identifi
patient
greatest
risk
wheez
viral
infect
whose
virusinduc
wheez
herald
onset
asthma
would
key
step
prevent
therapi
could
focus
group
greatest
need
next
year
genebyenviron
interact
elucid
particularli
way
innat
immun
system
defect
impact
sever
viral
infect
incept
asthma
addit
improv
understand
whether
host
factor
epitheli
cell
function
immun
respons
versu
virul
viru
strain
import
incept
asthma
viral
infect
identif
preasthma
phenotyp
use
novel
biomark
facilit
improv
identif
atrisk
popul
use
effect
treatment
strategi
respiratori
tract
infect
caus
virus
chlamydophila
mycoplasma
hypothes
signific
role
pathogenesi
asthma
particular
virus
associ
infantil
wheez
theoriz
lead
incept
asthmat
phenotyp
children
experi
sever
viral
respiratori
infect
earli
life
like
asthma
later
childhood
children
adult
establish
asthma
viral
upper
respiratori
tract
infect
play
key
role
produc
acut
exacerb
may
lead
healthcar
util
chlamydophila
mycoplasma
infect
may
contribut
acut
exacerb
sever
chronic
asthma
sever
host
factor
allerg
sensit
epitheli
barrier
defens
virusinduc
interferon
respons
modifi
risk
asthma
incept
virusinduc
wheez
contribut
may
vari
respect
earlyversu
adultonset
diseas
upper
airway
infect
viral
replic
epitheli
cell
lysi
occur
releas
viru
particl
danger
signal
includ
atp
act
stimul
resid
antigenpres
cell
dendrit
cell
defens
mechan
includ
epitheli
cell
product
interferon
initi
apoptosi
limit
viral
product
dendrit
cellderiv
chemokin
initi
recruit
granulocyt
lymphocyt
assist
viral
clearanc
attenu
ifn
product
andor
pore
function
correl
less
upper
airway
inflamm
greater
risk
acut
asthma
symptom
may
result
lower
airway
infect
subsequ
epitheli
cell
injuri
presenc
